logo

A Tale of Resilience: Inozyme Pharma Inc Amid Stock Market Turbulence

Inozyme Pharma Inc’s stock has seen a smooth market performance. The company’s stock achieved a 1-year high of $7.80 on 04/01/24, and the lowest price during that time was $2.69, recorded on 10/27/23.

52-week price history of INZY Stock

A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Inozyme Pharma Inc’s current trading price is -16.74% away from its 52-week high, while its distance from the 52-week low is 141.35%. The stock’s price range during this period has fluctuated between $2.69 and $7.80. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 1.12 million for the day, which was evidently higher than the average daily volume of 0.56 million over the last three months.

Financial Performance and Market Capitalization

Inozyme Pharma Inc (INZY) has experienced a quarterly rise of 55.64% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 400.89M and boasts a workforce of 59 employees.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 4.95, with a change in price of +3.39. Similarly, Inozyme Pharma Inc recorded 514,561 in trading volume during the last 100 days, posting a change of +109.35%.

INZY Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for INZY stands at 0.33. Similarly, the long-term debt-to-equity ratio is also 0.33.

INZY Stock Stochastic Average

The raw stochastic average for Inozyme Pharma Inc over the last 50 days is presently at 60.51%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 44.11%. Further, the company’s Stochastic %K and %D values for the last 20 days were 60.10% and 70.56%, respectively.

INZY Stock Price Performance Analysis

Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. This year’s metric has recorded a Price increase of 52.35%. However, over the past six months, we’ve seen a weaker performance of 78.79%. The price of INZY fallen by 4.34% over the last 30 days. And in the last five days, it has fallen by -12.18%.